Key facts
- Notable investors include Shenyang Information Industry Venture Capital, Zhongtian Liaochuang Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Tianfeng Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Tianfeng Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Tianfeng Biotechnology
Manufacturer of pharmaceuticals intended for therapeutic and clinical treatment purposes. The company offers research and development of active compounds, standardized production processes, quality assurance systems, regulatory compliance, and distribution channels for medical use, enabling healthcare markets to access consistent therapeutic agents, support patient care, maintain treatment reliability, and achieve broad application across oncology, infectious disease, and other specialized medical fields through controlled and scalable biopharmaceutical solutions.
- Sector
- Healthcare
- HQ
- Shenyang, China
- Founded
- 2005
- Employees
- 28
- Website
- taxol.com.cn/
- Ownership
- Privately Held (backing)
Tianfeng Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Tianfeng Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Tianfeng Biotechnology in its N-PORT filings yet. We sweep new filings monthly.